The Effects of Eight Weeks Aerobic Interval Exercise with Variable Volume on the Cardiovascular Risk Factors and Liver Enzymes of Women with Dyslipidemia

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 330

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JNFH-8-2_007

تاریخ نمایه سازی: 29 مرداد 1399

Abstract:

Introduction: Metabolic dyslipidemia could lead to non-alcoholic fatty liver disease, and its secondary consequence is the development of metabolic syndrome and diabetes. The present study aimed to investigate the effects of eight weeks of aerobic interval exercise with variable volumes on the cardiovascular risk factors and liver enzymes of the women with dyslipidemia. Methods: This quasi-experimental study was conducted on 30 middle-aged women with high blood lipids. The patients were selected and divided into three groups of low-volume training (three sessions per week; n=10; LVT), high-volume training (four sessions per week; n=10; HVT), and control (n=10; C).The exercise program was implemented in eight weeks 3-4 sessions per week for 45-60 minutes with the intensity of 65-75% of the maximal heart rate. The inter-group and intra-group comparison were performed using student s t-test, and one-way analysis of variance (ANOVA) was used to assess the differences between the groups. Results: In the training groups, a significant reduction was observed in weight (LVT: 72.01 vs. 67.26, HVT: 72.80 vs. 68.06), body mass index (LVT: 28.19 vs. 26.31, HVT:27.85 vs. 26.04), body fat (LVT: 26.86 vs. 25.69, HVT:27.21 vs. 25.91), waist-to-hip ratio (LVT: 1.05 vs. 1.03, HVT:1.07 vs. 1.05), alanine transaminase(LVT: 46.60 vs. 39.60, HVT: 43.80 vs. 38.50), aspartate transaminase(LVT: 36.50 vs. 31.00, HVT: 33.50 vs. 29.40), and triglyceride (LVT: 171.80 vs. 163.60, HVT:176.90 vs. 161.40). However, the maximum oxygen uptake increased significantly after the intervention in both the training groups (LVT: 32.17 vs. 35.93, HVT:30.93 vs. 35.98). The levels of total cholesterol (211.20 vs. 204.90) and low-density lipoprotein cholesterol (134.13 vs. 126.68) significantly decreased only in the LVT group, while no such changes were observed in the HVT group. In addition, the systolic blood pressure (LVT: 135.40 vs. 128.60, HVT: 137.00 vs. 129.60) decreased significantly in both groups, while no significant change was observed in the diastolic blood pressure. Conclusion: According to the results, eight weeks of aerobic interval exercise could improve the cardiovascular risk factors, liver enzymes, and body composition of the women with dyslipidemia. Therefore, it is recommended that some cardiovascular risk factors and liver enzymes of women with dyslipidemia be used for the improvement of these patients.

Authors

Reyhaneh Zolfaghari

Student of Exercise Physiology, Faculty of Sport Sciences, Hakim Sabzevari University, Sabzevar, Iran.

Amirhossein Haghighi

Associate Professor of Exercise Physiology, Faculty of Sport Sciences, Hakim Sabzevari University, Sabzevar, Iran.

Roya Askari

Assistant Professor of Exercise Physiology, Faculty of Sport Sciences, Hakim Sabzevari University, Sabzevar, Iran.

Keyvan Hejazi

Assistant Professor of Exercise Physiology, Faculty of Sport Sciences, Hakim Sabzevari University, Sabzevar, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Srikanth S, Deedwania P. Management of dyslipidemia in patients with ...
  • Georgiadis AN,Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis ...
  • Kannel WB. Lipids, diabetes, and coronary heart disease: insights from ...
  • Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and ...
  • Onat A, Can G, Hergenç G, Yazici M, Karabulut A, ...
  • Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, ...
  • Wilmot KA, O Flaherty M, Capewell S, Ford ES, Vaccarino ...
  • Ahmed A, Wong RJ, Harrison SA. Nonalcoholic fatty liver disease ...
  • Manimmanakorn A, Hamlin MJ, Ross JJ, Taylor R, Manimmanakorn N. ...
  • Davoodi M, Moosavi H, Nikbakht M. The effect of eight ...
  • Shamsoddini A, Sobhani V, Ghamar Chehreh MH, Alavian SM, Zaree ...
  • Fathei M, Khairabadi S, Ramezani F, Hejazi K. The effects ...
  • Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, ...
  • De Piano A, do Prado WL, Caranti DA, Siqueira KO, ...
  • Valizadeh A, Yousefi Bilehsavar O, Abdi H, Jahanshahi Z, Madadi ...
  • Khaoshbaten M, Gholami N, Sokhtehzari S, Monazami AH, Rostami Nejad ...
  • Valizadeh R. Nikbakht M, Davodi M, Khodadoost M. The effect ...
  • Yao J, Meng M, Yang S, Li F, Anderson RM, ...
  • Zeinvand lorestani A, Mirnasouri R, Rahmati M. The effect of ...
  • Park JH. Kim HJ, Han A, Kang DM, Park S. ...
  • Braith RW, Graves JE, Pollock ML, Leggett SL, Carpenter DM, ...
  • Balducci S, Cardelli P, Pugliese L, D Errico V, Haxhi ...
  • Haghighi AH, Gelardi N, Hamedinia MR. The Effect of an ...
  • Swain DP, Abernathy KS, Smith CS, Lee SJ, Bunn SA. ...
  • Mottillo EP, Shen XJ, Granneman JG. Role of hormone-sensitive lipase ...
  • DeLany JP, Kelley DE, Hames KC, Jakicic JM, Goodpaster BH. ...
  • Blundell JE, Finlayson G, Gibbons C, Caudwell P, Hopkins M. ...
  • McLaughlin T, Lamendola C, Coghlan N, Liu TC, Lerner K, ...
  • Hsieh CJ, Wang PW, Chen TY. The relationship between regional ...
  • Yari Z, Rahimlu M, Poustchi H, Ebrahimi Daryani N, Hekmatdoost ...
  • Baldi JC, Wilson GA, Wilson LC, Wilkins GT, Lamberts RR. ...
  • Henriksen EJ. Invited review: Effects of acute exercise and exercise ...
  • Borghouts LB, Keizer HA. Exercise and insulin sensitivity: a review. ...
  • Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. ...
  • Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. ...
  • Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, ...
  • Recasens M, Ricart W, Fernández-Real JM. Obesity and inflammation. Rev ...
  • McManaman JL, Bales ES, Orlicky DJ, Jackman M, MacLean PS, ...
  • Plotnikoff RC, Courneya KS, Trinh L, Karunamuni N, Sigal RJ. ...
  • Durstine JL. Action plan for high cholesterol. Human Kinetics; 2006. ...
  • Takahashi S. Triglyceride rich lipoprotein-LPL-VLDL receptor and Lp (a)-VLDL receptor ...
  • Ahn N, Kim K. High-density lipoprotein cholesterol (HDL-C) in cardiovascular ...
  • Mittendorfer B, Yoshino M, Patterson BW, Klein S. VLDL triglyceride ...
  • Despres JP,Moorjani S, Tremblay A, Poehlman ET, Lupien PJ, Nadeau ...
  • نمایش کامل مراجع